Abstract: Cardiovascular diseases (CVD) are the leading cause of death in humans, particularly in postmenopausal women. Inflammation has been shown to play a basic role in the development of CVD. In light of the involvement of adipocytokines and dietary lipids in the induction of inflammation in CVD, this study was conducted to investigate the potential relationship between dietary lipids and two well-known adipocytokines, visfatin and adiponectin.
INTRODUCTION
Cardiovascular diseases, which increase dramatically after menopause, are the leading cause of death among chronic noncommunicable disorders [1] . Inflammation plays a basic role in the development of CVD by inducing oxidative stress [2] , injury, and cellular aging in coronary arteries [3, 4] . Recently, researchers have shown increased interest in the role of inflammatory and antiinflammatory adipocytokines in the progression of CVD [5, 6] . Visfatin, a well-known inflammatory adipocytokine, has been shown to be involved in many inflammatory diseases [7] . This adipocytokine reportedly accelerates monocyte adhesion to endothelial cells [8] , and the expression of visfatin is elevated at plaque rupture sites [9] in patients with unstable atherosclerotic lesions. Moreover, adiponectin has been recognized as a novel antiinflammatory adipocytokine [10] , and it has been suggested that adiponectin administration may prevent vascular stenosis [11] , insulin resistance, *Address correspondence to this author at the Deputy for Research, Bushehr University of Medical Sciences, Moallem Street, Bushehr, P.O. Box-3631, I.R. Iran; Tel: 0098 9724601774; Fax: 0098 7712528; E-mail: rahbar_alireza@yahoo.com atherosclerosis [12] , renal fibrosis, diabetes nephropathy and albuminuria in animal models [13] .
To date, the strongest support for protection against CVD has been found for the "Mediterranean" dietary pattern, with an optimal dietary fat profile that includes a low intake of saturated fatty acids and n-6 polyunsaturated fatty acids, and a moderate intake of n-3 fatty acids [14] . Elevated intakes of foods such as vegetables and fruits as sources of dietary fiber are also crucial in the Mediterranean diet [14] . However, some studies have noted that short-term consumption of the Mediterranean diet has little effect on the concentrations of a number of adipokines [15] .
Reducing SFA intake is the hallmark of dietary recommendations to reduce CVD, mainly because of their effect on blood cholesterol [16] . Interestingly, evidence has also shown that increased n-6 PUFA intake may result in an increased risk of coronary artery disease in populations where this increase cannot be explained by conventional risk factors [17] . To date, however, there has been little discussion about the mechanisms involved in the role of dietary lipids in CVD. Accordingly, we hypothesized that dietary lipids, in addition to the mechanisms reported previously, might influence CVD by modulating the expression of some adipocytokines. Therefore this study was conducted in postmenopausal women who were highly susceptible to CVD in order to determine the potential relationship between dietary fatty acid, cholesterol and fiber intakes and serum visfatin and adiponectin levels. Our aim was ultimately to discover potential approaches to dietary modification in order to reduce the incidence of CVD.
PARTICIPANTS AND METHODS

Study Design and Participants
A sample size of 378 postmenopausal women was estimated for this study. The participants were selected from our previous study population in Bushehr port, as described elsewhere [18] . The objectives of the study were described in local mass media programs to motivate public interest. In accordance with a predicted loss of approximately 10% due to low interest by some individuals, 416 community-dwelling and ambulatory postmenopausal women from 13 stratified geographical areas were selected randomly. An invitation letter was delivered to individual participants, who were asked to come to the research center at 7.00 hours the next morning after an overnight fast. The aims of the study and its roll in health and diseases in postmenopausal women were explained at that time. The criteria for enrolment in the study were age 50 years or older, female gender, postmenopausal status, no cigarette or tobacco use, no antiinflammatory medication, and no medical history of inflammatory diseases such as arthritis, thyroiditis, inflammatory bowel disease, lupus erythematosus, etc. In this study postmenopausal status was defined as age older than 50 years, absence of menstruation for at least 12 months previously, or ovariectomy or hysterectomy.
The study was approved by the Ethics Committee of our center and was carried out in accordance with the principles of the Declaration of Helsinki as revised in 2000. Informed consent was obtained from all individuals.
Measurements of Serum Parameters
Venous blood samples were obtained between 8.00 and 9.00 hours and centrifuged at 3000 g for 15 min at 4°C. Immediately after centrifugation, the serum samples were frozen and stored at -80 °C for a period of no more than 6 weeks.
To detect visfatin in the serum samples, a commercially available enzyme-linked immunosorbent assay kit (ELISA) (Adipo-Gen, Seoul, Korea, Cat. No. V0523EK) was used according to the manufacturer's instructions. The assay sensitivity for visfatin was 0.10 ng/mL; the intra-and interassay coefficients of variance were 3.8%-5.5% and 6.4%-9.5%, respectively.
To detect adiponectin in the serum samples, a commercially available ELISA kit (AdipoGen, Incheon, Korea, Cat. No. AG-45A-0001EK-KI01) was used according to the manufacturer's instructions. The limit of detection of the assay was 100 pg/mL; the intra-and inter-assay coefficients of variance were 2.9%-3.8% and 2.8%-5.5%, respectively. C-reactive protein was measured with a high-sensitivity CRP assay and CRP HS kit (DRG International, Springfield, USA) The minimum concentration of CRP detectable by the ELISA was estimated at 0.1 mg/L. In addition, functional sensitivity was determined to be 0.1 mg/L according to an inter-assay coefficient of variation of 20%. Plasma glucose concentration was measured with a glucose analyzer (YSI, Yellow Springs, OH, USA).
Current dietary intake was obtained through an interview conducted by trained dietitians. We determined the portion size and annual, monthly, and weekly frequencies of intake with a food frequency questionnaire. In addition, all women completed a 24-hour dietary recall for 3 nonconsecutive days. The FFQ showed a correlation coefficient of 0.85 with 24-recall dietary recall. The reproducibility and relative validity of the 168-item FFQ were tested previously in the Tehran Lipid and Glucose Study [19] . Each food and beverage was analyzed for the content of energy and other nutrients with Nutritionist III software (version 7.0; NSquared Computing, Salem, OR, USA), which was adapted for Iranian foods.
Anthropometric Measurements
Height and weight were measured with a stadiometer. Heavy outer garments and shoes were removed before height and weight were measured. Body mass index was calculated as kg weight/m 2 height.
Waist circumference was measured with an unstretchable measuring tape at the midpoint between the lower edge of the rib cage and the iliac crests. Waist-to-hip ratio was determined as waist circumference/hip circumference. For this parameter waist circumference was defined as the minimal circumference measured at the navel, and hip circumference was defined as the widest circumference measured at the hips and buttocks.
Statistical Analysis
The distribution of variables was studied with probability plots and the Shapiro-Wilks test. The relationship of the two adipocytokines with dietary components and anthropometric measures was determined by calculating Pearson's correlation coefficient. Partial correlation analyses were done with adjustment for age, WHR and BMI. Multiple linear regression models were used to determine the association between dietary SFA, monounsaturated fatty acid, PUFA and fiber intake (independent variables) and circulating adipocytokine levels (dependent variables). To estimate the association of adipocytokines with diabetes, we used a general linear model adjusted for age and BMI. A value of p<0.05 was accepted as significant.
The postmenopausal women were also divided into the highest and lowest quartiles of SFA, n-6 PUFA and cholesterol. Analysis of variance was used to identify significant differences between quartiles.
All statistical analyses were done with an IBM computer and the SPSS v. 15 statistical software package (SPSS Inc., Chicago, IL).
RESULTS
A total of 374 women were included, for a response rate of 83%. Their mean (±SD) age was 58.82 (±7.82) years. The age distribution of the population we studied was 68.1% between 50 and 60 years, 21.9% between 61 and 70 years, 9.2% between 71 and 80 years, 0.5% between 81 and 90, and 0.3% >90 years. Table 1 shows the basic characteristics of the postmenopausal women and their dietary intakes of energy, protein, carbohydrates, total fat, cholesterol, SFA, MUFA and PUFA.
Visfatin
Bivariate correlation analysis showed a correlation between serum visfatin level and dietary SFA, cholesterol and n-6 PUFA intake. This significant relationship persisted after adjustment for age, diabetes, total energy intake and BMI ( Table 2 ). In the multiple regression analyses, serum visfatin level showed a significant positive correlation with dietary SFA (β=0.06, p=0.01), dietary n-6 PUFA (β=0.02, p=0.02) and dietary cholesterol (β=0.005, p=0.002) after controlling for age, diabetes, total energy intake and BMI (Table 3) . However, no significant association was found between serum visfatin and dietary MUFA intake or serum fasting blood sugar concentration (p>0.05, Tables 2 and 3) . No significant differences in visfatin levels were seen between patients with and without diabetes (3.69±2.53 ng/mL vs 3.21±2.05 ng/mL; p>0.05).
The participants were divided into the highest and lowest quartiles of serum SFA, n-6 PUFA and cholesterol concentrations. The distribution of serum visfatin levels according to quartiles of SFA, PUFA and cholesterol intake is shown in Figs. (1, 2 and 3) . There was significant increase in serum visfatin in the highest quartile compared to the lowest quartile. Mean quartile estimates (Q1-Q4) for dietary SFA were 1 Analysis by quartiles of dietary SFA showed a significant increase in visfatin in quartile 4 compared to quartile 1 (3.73±2.58 vs 2.74±1.67 ng/mL, p=0.01) (Fig. 1) . Analysis by quartiles of dietary n-6 PUFA intake also revealed a significantly higher visfatin level in quartile 4 compared to quartile 1 (3.73±2.28 vs 3.05±2.02 ng/mL, p=0.04) (Fig. 2) . For dietary cholesterol intake, analysis by quartiles showed a significant increase in visfatin in quartile 4 compared to quartile 1 (3.49±2.59 vs 3.25±2.23 ng/mL; p=0.05) (Fig. 1) .
Adiponectin
There were no significant associations between serum adiponectin level and dietary SFA, n-6 PUFA and MUFA intake (Tables 1 and 3) . Analysis by quartiles of dietary n-6 PUFA, SFA and cholesterol intake showed no significant differences in adiponectin level between quartiles. Ageadjusted and -unadjusted adiponectin levels showed a significant inverse correlation with BMI ( Table 2 ). The concentration of adiponectin was significantly lower in individuals with diabetes compared to women without diabetes (9.87±4.74 µg/mL vs 13.22±10.32 µg/mL; p=0.005). The negative association between adiponectin and serum FBS was significant both before and after adjustment for age and BMI ( Table 2) .
High-Sensitivity C-Reactive Protein
In the bivariate analysis, visfatin showed a positive correlation and adiponectin showed a negative association 
DISCUSSION
In our sample of postmenopausal women, dietary SFA intake showed a significant positive relationship with serum visfatin concentration. Visfatin has been recognized as a proinflammatory agent and it appears to be a key cytokine involved in a broad spectrum of chronic inflammatory disorders [8, 9] . After entering the circulation, dietary SFA acts through several biochemical pathways in addition to its basic role in energy production. One of these metabolic pathways involves the modulatory effect of SFA on inflammatory responses. It has been reported that SFA upregulates the inflammatory mediator nuclear factor kappaenhancer of activated B cells in humans [20] . The stimulation of NF-kB by SFA has been reported to induce interleukin-6 secretion [20] ; in turn, IL-6 increases the expression of the visfatin gene [21] (Fig. 4) . In agreement with our findings, Haghighatdoost and et al. reported an increased level of circulating visfatin after a high intake of SFA in humans [22] .
Our findings also showed a direct association between dietary PUFA intake and serum visfatin level. This is consistent with several studies that found that n-6 PUFA intake in association with high levels of proinflammatory cytokines such as IL-6 and CRP in the diseased state [23] (Fig. 4) . In chronic obstructive pulmonary disease, a complex chronic inflammatory condition, a direct association between dietary intake of n-6 PUFA and serum inflammatory markers was observed [23] . The susceptibility of PUFA to peroxidation is a plausible explanation for the association we observed between visfatin level and dietary n-6 PUFA intake. It should be borne in mind that the double bond in PUFA is easily attacked by free radicals and oxidized into lipid peroxides when PUFA S are exposed to oxidant stress [24] . Lipid peroxidation is reported to be an important mechanism involved in the pathogenesis of inflammation by dietary PUFA [25, 26] .
Based on the present findings, dietary cholesterol was responsible, at least in part, for evoking inflammatory responses. In this study the consumption of larger amounts of cholesterol in the daily diet was a significant predictor of elevated serum visfatin. The impact of cholesterol in several inflammatory markers such as NF-kB was previously reported by Kleemann et al. [27] . The increased in NF-kB by cholesterol stimulates the production of IL-6 [20] , which can in turn lead to increasing visfatin gene expression [22] (Fig. 4) . Accordingly, the action of cholesterol in inflammatory disease might be explained, at least in part, through its modulatory impact on visfatin secretion.
Our data showed higher visfatin levels in participants with higher BMI and WHR compared to women with normal BMI and WHR. In fact, obesity is now considered a condition that facilitates the development of a low-grade inflammatory state characterized by increased plasma levels of proinflammatory adipokines [28] . Seemingly, the lowgrade inflammation associated with obesity is a potential contributor to the increased visfatin levels in the current study [8, 29] . In support of our findings, several reports have demonstrated that visfatin level increases dramatically in obese patients [30] .
In this study visfatin was appeared to act as an inflammatory cytokine, whereas other reports noted an insulin-mimetic role for visfatin. To explain this dilemma in relation to the role of visfatin in diabetes control or inflammation, it should be considered that visfatin initially occurs in two forms: extracellular (cytokine-like) and intracellular (enzymatic). The extracellular form stimulates the phosphorylation of insulin-receptor substrate-1 and tyrosine protein kinase B [31] . However, the original study that described visfatin binding to insulin receptors has been retracted [31] . Recently the role of visfatin as an inflammatory mediator has been questioned. Some in vivo CVD studies reported that the pharmacological inhibition of visfatin diminishes the severity of arthritis and reduces cytokine secretion in inflamed joints [32] . Thus visfatin appears to be involved in inflammation independently of its relation with insulin receptor signaling pathways, but through its effect on other related tyrosine kinase receptors such as the insulin-like growth factor receptor. The proinflammatory property of visfatin may also be due to intracellular enzymatic activity, as the inducible nitric oxide synthesis in vascular smooth muscle cells is prevented by APO866, an inhibitor of visfatin enzymatic activity. In addition, some research has suggested that the inflammatory effect of visfatin is due to its role in prostaglandin E release [33] .
Our findings also showed a significant correlation between visfatin level and CRP, whereas no relationship was observed between serum visfatin level and FBS level or diabetes.
In the present study, dietary MUFA, in contrast to dietary PUFA, did not predict visfatin level as a proinflammatory cytokine. One dietary approach used to reduce the susceptibility of low-density lipoprotein to lipid peroxidation is the partial substitution of dietary PUFA with MUFA [34, 35] . Indeed, MUFA are more resistant to oxidative modification than PUFA, and unlike SFA, do not induce hyperlipidemia [36] . It has been reported that MUFA modulates the synthesis of inflammatory cytokines via activation of the peroxisome proliferative activated receptor [37] . The consumption of olive oil or walnuts as sources of MUFA, in comparison to a butter-enriched diet as the source of SFA, decreased the postprandial expression of inflammatory cytokines in peripheral blood mononuclear cells of healthy men [38] . In contrast to our findings, an in vitro study by Karrasch and colleagues found that in cultures of 3T3-L1 adipocytes, different fatty acids had different effects on visfatin release: palmitic and palmitoleic acid downregulated release, whereas oleic acid (MUFA) increased release [39] .It should be considered, in this connection, that the interpretation of studies done in vivo studies is much more problematic than in vitro studies done under controlled conditions. To elucidate the impact of dietary MUFA on visfatin levels, interventional studies under controlled conditions will be needed.
We found no association between any of the dietary fatty acids and adiponectin. Interventional trials designed around acute changes in diet have yielded mixed results, with evidence of an increase [40] , a decrease [41] or no change in adiponectin levels [42] . Epidemiological evidence regarding the relationship between dietary intake and circulating adiponectin is also inconclusive. A study by Pischon and colleagues [43] in 532 men showed that a diet rich in carbohydrates, which promote glycemia, was associated with lower concentrations of adiponectin. However, a study by Yannakoulia and coworkers [44] in a group of 114 individuals failed to find significant correlations between total energy (or any macronutrient) and serum adiponectin levels. The concentration of adiponectin relative to other cytokines in the circulation may be too high to be influenced by variations in dietary fatty acids at physiological doses [45] . It has been reported plasma levels of adiponectin range from 5 to 30 mg/L in normal weight individuals, representing 0.01% of all plasma proteins [46] . In fact, the normal plasma concentration of adiponectin is at least 1000-fold greater than visfatin ( Table 1) .
As a potential limitation of our study, we note that the results of cross-sectional studies do not establish causal relationships. However, they do reveal associations among variables that can suggest potential mechanisms of action, and that are useful for generating hypotheses that merit further investigation in intervention studies.
Another potential limitation is that the nutritional software we used was not able to analyze n-3 fatty acid content in the diet; therefore we were unable to evaluate the relationships between n-3 fatty acids and visfatin concentration. It is nonetheless noteworthy that the data for nutrient intakes from our survey were obtained from food recall records and a food frequency questionnaire, and were based on the classification of dietary standards for epidemiological studies. Accordingly, assuming that our interpretation of these data is valid, and this source of data is a potential strength of this study.
CONCLUSION
The findings of the study indicate that certain dietary nutrients might be associated with higher serum visfatin levels, and suggest that postmenopause-induced inflammatory responses might be suppressed, at least in part, by dietary modification. The physiology of the cytokine visfatin has begun to be elucidated, but its role in inflammation is still controversial. We found no significant correlation between any dietary fatty acids and circulating adiponectin concentration. 
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